| Identification | Back Directory | [Name]
L-Lysine S-(carboxymethyl)-L-cysteine | [CAS]
49673-81-6 | [Synonyms]
Fluifort
CARBOCISTEINE LYSINATE
Lysine-S-Carboxymethyl-L-Cysteine
S-Carboxymethyl-L-cysteine lysinate
L-Lysine S-(carboxymethyl)-L-cysteine
L-Lysine S-(carboxymethyl)-L-cysteine (1:1)
2-amino-3-(carboxymethylthio)propanoic acid
L-Lysine S-(carboxymethyl)-L-cysteine USP/EP/BP
L-lysine, compound with S-(carboxymethyl)-L-cysteine (1:1)
(2R)-2-amino-3-(carboxymethylsulfanyl)propanoicacid,(2S)-2,6-diaminohexanoicaci
(2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acid,(2S)-2,6-diaminohexanoic acid
(R)-2-Amino-3-((carboxymethyl)thio)propanoic acid (S)-2,6-diaminohexanoic acid (1:1)
(R)-2-Amino-3-((carboxymethyl)thio)propanoic acid compound with (S)-2,6-diaminohexanoic acid (1:1) | [EINECS(EC#)]
256-425-9 | [Molecular Formula]
C11H23N3O6S | [MDL Number]
MFCD00798275 | [MOL File]
49673-81-6.mol | [Molecular Weight]
325.38 |
| Hazard Information | Back Directory | [Uses]
Fluifort is used in anti-cancer treatment as a selective scavenger of reactive oxygen intermediates. | [Flammability and Explosibility]
Notclassified |
|
|